RICHARDSON, Texas, July 24, 2020 Ikonopedia announced today that Intermountain Healthcare, based in Salt Lake City, Utah, has selected the company’s structured breast reporting and risk assessment tools to help improve reporting quality, efficiency, and maintain patient safety.

The system-wide implementation will be initiated at six Intermountain Healthcare’s hospitals, including the Janice Beesley Hartvigsen Breast Care Center at Intermountain Medical Center, and features integration with the Cerner EHR and other imaging systems.

Intermountain Healthcare employs nearly 40,000 caregivers who serve the healthcare needs of people across the Intermountain West.  Intermountain Healthcare performs more than 160,000 mammography exams a year, as well as provides comprehensive treatment for breast cancer and other breast-related conditions, at more than 25 locations in Utah, southern Idaho, and southern Nevada.

Intermountain Healthcare was named as one of “Health Care’s Most Wired” for 2016 by Hospitals & Health Networks magazine. The list is based on a collaborative study conducted by H&HN and the American Health Association.  Intermountain has been named among the nation’s most technologically savvy hospital systems in 17 of the 18 years the survey has been conducted.

“While we expect Ikonopedia’s innovative Cloud-based structured breast reporting system to bring significant efficiency gains to our technologists and radiologists, the focus is on providing high-quality and safe care to every one of our patients,” said Brett Parkinson, MD, imaging director and medical director for breast care services at Intermountain. “This starts with utilizing intuitive, easy to use reporting and risk assessment tools and closed-loop follow-up system to make sure that every patient and every clinical finding is monitored and fully resolved.”

Ikonopedia is an innovative structured breast reporting and MQSA management system designed to dramatically improve reporting efficiency and optimize facility operations. All findings are saved as discrete data, which allows Ikonopedia to prevent errors, maintain BI-RADS-compliant language and automate many time-consuming processes.  Ikonopedia makes it possible to eliminate laterality errors, automatically choose exam-appropriate patient letters, and pull forward findings from past exams along with many other time-saving features.

Ikonopedia’s integrated risk assessment tool is now available in dozens of languages and risk data is used to create alerts for the radiologist, populate the clinical section of the report, and automatically update the patient letter. A high-risk patient alert identifies patients with a 20% or greater lifetime risk and information about the score is instantly viewable.

“Intermountain Healthcare is well known for using technology to improve patient care, efficiency, and safety.  We are proud to work with Intermountain to deliver robust breast reporting and risk-assessment tools that help ensure that women get accurate and timely information about their breast care, which can lead to better outcomes for their patients and caregivers,” said Emily Crane, CEO of Ikonopedia.


About Ikonopedia

Ikonopedia was founded by three expert breast imaging Radiologists: László Tabár, MD, is the author of 6 books in 10 languages on mammography and a world renowned educator;  A. Thomas Stavros, MD, is the author of one of the most popular reference books in the field of breast ultrasound; and Michael J. Vendrell, MD, is an expert in breast MRI and CAD design with extensive experience in breast-imaging software. For more information, visit

#   #   #

Media Contacts:

Emily Crane

Diagnostic AI and reporting technologies seamlessly integrated to assist radiologists in breast MRI evaluations, furthering a commitment to innovation within the breast imaging space

CHICAGO, July 13, 2020 – Qlarity Imaging, a leading diagnostic artificial intelligence (AI) company that developed QuantX, the first U.S. Food and Drug Administration (FDA)-cleared computer-aided diagnosis software for breast MRI analysis, and Ikonopedia, creators of the first and only cloud-based structured breast reporting and risk assessment system designed to dramatically improve reporting efficiency and optimize facility operations, today announced their partnership to advance breast cancer diagnosis and reporting. The collaboration leverages next-generation technologies to provide an integrated software solution that increases accuracy and optimizes workflows for radiologists performing breast MRI evaluations.

“By combining our proven diagnostic AI technology with Ikonopedia’s powerful reporting software, we are strengthening and enhancing the tools available for the diagnosis of breast cancer,” said Qlarity Imaging Chief Executive Officer Jon DeVries. “Creating a streamlined workflow that delivers more accurate diagnoses, reduces the risk of reporting errors, and saves time can help radiologists overcome challenges associated with ever growing exam volume and data complexity—which are intensifying in today’s environment—to improve patient care.”  

A key partnership component is the seamless integration of data-driven analysis from QuantX into Ikonopedia’s closed-loop structured breast reporting system. Instead of typing or dictating results into the reporting application, the location, size, kinetics, and QuantX score are automatically transferred into Ikonopedia. The auto-population of lesion-specific details helps increase accuracy by reducing the risk of errors caused by manual entry and boosts productivity. While integrating the diagnostic and reporting workflow can yield efficiency gains and cost savings for radiologists and health systems, the most critical benefit is felt by patients where increased accuracy can lead to earlier detection of breast cancer.

“Our partnership with Qlarity Imaging is a natural progression as we are both leading technology innovators in the breast imaging space,” said Ikonopedia Chief Executive Officer Emily Crane. “We also share the ultimate goal of improving patient care to help more women become breast cancer survivors; a goal we are one step closer to achieving.”

To explore the Qlarity Imaging and Ikonopedia partnership, including a short demo video of the software integration, click here.

About Ikonopedia

Ikonopedia is the first and only secure, cloud-based breast reporting and MQSA management system designed to track individual lesions in all categories of care to significantly improve patient safety. This closed-loop system increases reporting efficiencies and radiologist awareness with helpful clinical warnings and timely alerts for pertinent patient and family history. Ikonopedia was founded by three expert breast imaging radiologists: László Tabár, MD, is a world renowned educator and the author of six books in 10 languages on mammography;  A. Thomas Stavros, MD is the author of one of the most popular reference books in the field of breast ultrasound; and Michael J. Vendrell, MD is an expert in breast MRI and CAD design. For more information, please visit

About Qlarity Imaging 

Qlarity Imaging improves patient care by building AI-driven breast imaging solutions that enhance diagnostic insights. The company’s vision is to transform women’s imaging with AI technologies that advance the detection and diagnosis of breast cancer. Qlarity’s award-winning initial product, QuantX, is the first computer-aided diagnosis software to be cleared by the FDA for breast MRI evaluation. Qlarity Imaging is a portfolio company of Paragon Biosciences, a life science innovator that creates, invests in and builds life science companies in artificial intelligence, cell and gene therapy, synthetic biology and biopharmaceuticals. For more information, please visit

Indication: QuantX is indicated for evaluation of the assessment and characterization of breast abnormalities from MRI data in patients presenting for high-risk screening, diagnostic imaging workup, or evaluation of extent of known disease. QuantX is not intended for primary interpretation of digital mammography images.

Important Safety Statement: QuantX is not intended for primary interpretation of digital mammography images. Warnings and cautions related to the potential device failure or low performance are included in the User Manual including comments on image quality, patient population, and segmentation accuracy. Warnings and cautions related to the device are included in the User Manual. Information about the Similar Case Database and cases used in the MRMC study provided in labeling also provide information to users about potential limitations of the device related to specific subpopulations.

Dr. Peña describes herself as a coach’s wife and full-time working mom of three.  She is also a clinical pharmacist, passionate public speaker, and breast cancer survivor.

She is  founder and president of a non-profit organization;  The M.o.C.h.A.™️Tribe” (Mom Of a Child that Has Autism).  She writes a blog called The M.o.C.h.A Tribe Diaries — a website devoted to squashing the idea that autism has a single story.  She is also the Author of “Waiting for the Lightbulb” and a Today Show parenting team contributor.

Dr. Peña caught our attention with her video describing her personal experience with breast cancer beginning with consultation at the High-Risk Screening and Genetics Clinic at MD Anderson Center.  We were so moved with the video and her insightful emphasis on the lifesaving importance of early cancer detection, we wanted to share it with our readers.

SOUND ON🔈This 5 min video could save your life or the life of someone you love..It saved mine..You will want to click this link when your done.’re welcome for the grapefruit visual… there were other contenders… but they were inappropriate and not as comically subtle. Whatev..✌🏼&❤️#livinginthe5percent #cancersucks #purposeinpink #fightlikeagirl #survivor #breastcancerawareness The BreastiesSurvivorNet

Posted by Lisa A Peña on Wednesday, October 30, 2019


By Simon Häger, contributing writer

July 2, 2020 — Dr. László Tabár, a radiologist and oncologist from Falun, Sweden, is known worldwide as the “father” of mammography screening. He is certainly one of the key people behind the current national screening program for breast cancer in Sweden, but his research has also formed the basis for the introduction of screening programs in many other countries.

In this interview, Tabár shares the fascinating story of why he has dedicated the past 50 years of his life to introducing and improving mammography screening, and thereby reducing mortality in breast cancer — a journey colored by groundbreaking research results and success but also by opposition and a struggle to convince authorities of the benefits.

He gives us the story behind the introduction of mammography screening in Sweden and the intriguing results shown in two of his latest studies, published in 2018 and 2020, proving the benefits of screening independent of treatment regime — something he calls “one of the greatest accomplishments in clinical cancer research during the past 50 years.”


Dr. László Tabár in action by his breast imaging PACS workstation. Images courtesy of Dr. László Tabár.

Read the full article at Aunt Minnie